Listed

Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2013

Filed with the SEC on Jul 23, 2013 and accepted by EDGAR at Jul 23, 2013, 16:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-01-01 to 2013-03-31$362.8kus-gaap:SalesRevenueNet
Cost of revenue3 months2013-01-01 to 2013-03-31$115.8kus-gaap:CostOfRevenue
Gross profit3 months2013-01-01 to 2013-03-31$247.1kus-gaap:GrossProfit
Operating income3 months2013-01-01 to 2013-03-31−$202.6kus-gaap:OperatingIncomeLoss
Net income3 months2013-01-01 to 2013-03-31−$202.6kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-01-01 to 2013-03-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2013-01-01 to 2013-03-31−$58.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-03-31$49.3kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-03-31$645.4kus-gaap:AssetsCurrent
Total assetsAt period end2013-03-31$670.1kus-gaap:Assets
Current liabilitiesAt period end2013-03-31$567.0kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2013-03-31$103.1kus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001211524-13-000198. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.